Dr Mareike Ostertag is a member of the 2026 Expert Review Committee for the Access to Medicine Index. Prior to founding Cembramo Advisors, Mareike worked in the pharmaceutical industry for over 20 years, holding roles of increasing responsibility within Novartis. Her experience spans a wide range of areas, including technical marketing, research and development (R&D), business development and licensing and public affairs, most recently serving as Global Head, Policy Strategy for the Novartis Group.
Mareike’s has led teams, alliances and cross-industry working groups with members located around the world. She chaired the Advanced Therapy Medicinal Products working groups at EuropaBio and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) in addition to co-chairing the IFPMA's Pandemic Preparedness Working Group.Â
Since September 2023, she has served as Special Advisor to the Director General of IFPMA. In her role, she works with individual companies in the pharmaceutical and healthcare sector, trade associations, industry alliances and government entities. Mareike has lived and worked in Europe, the US and the Middle East.Â